In Vitro Diagnostics Market Size, Share, Trends, 2025 Growth and Forecast 2034

In 2024, the in vitro diagnostics market was estimated to be worth USD 80.02 billion. With a compound annual growth rate (CAGR) of 6.7% from 2025 to 2034, the market is expected to increase from USD 85.21 billion in 2025 to USD 152.62 billion.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Tests that identify illnesses, infections, and other conditions outside of the body, usually in a laboratory setting, are known as in vitro diagnostics, or IVDs. "In vitro" is derived from the Latin phrase "in glass." In contrast to IVDs, in vivo diagnostics include imaging tests like positron emission tomography, magnetic resonance imaging, and ultrasound scanning that are carried out directly on a patient. IVDs may consist of instruments, reagents, or other systems. They are employed in the diagnosis, treatment, and monitoring of medical conditions. Pregnancy tests, COVID-19 tests, HIV tests, and cancer diagnostics are a few types of IVD products.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/in-vitro-diagnostics-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐦𝐨𝐭𝐨𝐫𝐬:
• The need for early and accurate disease detection is driving the strong growth of the IVD market.
• One major factor propelling the in vitro diagnostics market is the growing aging population, particularly in developed countries.
• Point-of-care testing's incorporation into clinical practice promotes innovation. It increases diagnostic capabilities, propelling market expansion as global healthcare systems adopt these advanced tools more frequently in order to satisfy the rising demand for quicker and more accurate diagnostics.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
The in vitro diagnostics market will continue to grow as a result of major market players making significant investments in R&D to broaden their product lines. Some of the major participants in the market are:
• Abbott
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Qiagen

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/in-vitro-diagnostics-market/request-for-discount-pricing

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
• The market is primarily segmented based on product and service outlook, technology, specimen, application, end user, and region.
• Immunoassays, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, chromatography & mass spectrometry, and other technologies are included in the technology segment of the IVD market.
• Due to its widespread use and preference over alternative diagnostic techniques, the immunoassays segment held the largest share of the market.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/in-vitro-diagnostics-market/inquire-before-buying

𝐈𝐧 𝐕𝐢𝐭𝐫𝐨 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• The immunoassays segment leads the IVD market due to its high adoption, reliability, and accuracy, with methods like ELISA and lateral flow assays offering rapid, efficient results with minimal sample preparation.
• The infectious diseases segment dominates the IVD market due to the increasing global prevalence of diseases such as HIV, hepatitis, and multi-drug-resistant pathogens, driving demand for advanced diagnostic tools.
• North America dominated the in vitro diagnostics market and continued its dominance over the forecast period due to high chronic disease incidence, a strong market presence, and innovation in diagnostic testing.
• The global key market players include Abbott; Agilent Technologies, Inc.; Becton; Dickinson and Company; bioMérieux SA; Bio-Rad Laboratories, Inc.; Charles River Laboratories; Danaher Corporation; F. Hoffmann-La Roche Ltd.; and others

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭:
Idiopathic Pulmonary Fibrosis Treatment Market
https://www.polarismarketresearch.com/industry-analysis/idiopathic-pulmonary-fibrosis-treatment-market

Diagnostic Services Market
https://www.polarismarketresearch.com/industry-analysis/diagnostic-services-market

Natamycin Market
https://www.polarismarketresearch.com/industry-analysis/natamycin-market

Orthopedic Devices Market
https://www.polarismarketresearch.com/industry-analysis/orthopedic-devices-market

Multiphoton Microscopy Market
https://www.polarismarketresearch.com/industry-analysis/multiphoton-microscopy-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.